Lung cancer in elderly patients: A retrospective analysis of practice in a single institution

Critical Reviews in Oncology/Hematology

Volumn 64, Issue 1, 2007, Pages 43-48

  Madroszyk Flandin, Anne ^a   Bagattini, Sophie ^a   Gonçalves, Anthony ^a   Salem, Naji ^a   Viret, Frédéric ^a   Viallat, Jean Regis ^a   Rousseau, Frederique ^a   Protière, Christel ^a   Bertucci, Francois ^a   Maraninchi, Dominique ^a   Viens, Patrice ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Chemotherapy; Comorbidity; Comprehensive geriatric assessment; Elderly patients; Non small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEFITINIB; GEMCITABINE; NAVELBINE;

ADENOCARCINOMA; ADVANCED CANCER; AGED; CANCER CELL; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL COUNT; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEHYDRATION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GERIATRIC PATIENT; HEART FAILURE; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPERTHERMIA; KIDNEY FAILURE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; NEUTROPENIA; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; THROMBOEMBOLISM; TREATMENT RESPONSE; UNDIFFERENTIATED CARCINOMA;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34548433426     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2007.06.009     Document Type: Review

References (41)

1. Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer 80 (1997) 1273-1283
2. Hutchins L.F., Unger J.M., Crowley J.J., Coltman Jr. C.A., and Albain K.S. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341 (1999) 2061-2067
3. Earle C.C., Venditti L.N., Neumann P.J., Gelber R.D., Weinstein M.C., Potosky A.L., et al. Who gets chemotherapy for metastatic lung cancer?. Chest 117 5 (2000) 1239-1246
4. Yee K.W., Pater J.L., Pho L., Zee B., and Siu L.L. Enrollment of older patients in cancer treatment trials in Canada: why is age a barrier?. J Clin Oncol 21 8 (2003) 1618-1623
5. Lewis J.H., Kilgore M.L., Goldman D.P., Trimble E.L., Kaplan R., Montello M.J., et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21 7 (2003) 1383-1389
6. Townsley C., Pond G.R., Peloza B., Kok J., Naidoo K., Dale D., et al. Analysis of treatment practices for elderly cancer patients in Ontario. Can J Clin Oncol 23 16 (2005) 3802-3810
7. Gridelli C., Perrone F., and Monfardini S. Lung cancer in the elderly. Eur J Cancer 33 (1997) 2313-2314
8. Lilenbaum R. Management of advanced non-small-cell lung cancer in elderly populations. Clin Lung Cancer 5 3 (2003) 169-173 (Review)
9. Yancik R., and Ries L.A. Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14 1 (2000) 17-23
10. Brown J.S., Eraut D., Trask C., and Davison A.G. Age and the treatment of lung cancer. Thorax 51 (1996) 564-568
11. Earle C.C., Neumann P.J., Gelber R.D., Weinstein M.C., and Weeks J.C. J Clin Oncol 20 7 (2002) 1786-1792
12. Albain K.S., Crowley J.J., Leblanc M., and Livingston R.B. Survival determinants in extensive-stage non-small cell lung cancer: the southwest Oncology Group experience. J Clin Oncol 9 9 (1991) 1618-1626
13. Finkelstein D.M., Ettinger D.S., and Ruckdeschel J.C. Long-term survivors in metastatic non-small cell lung cancer: An Eastern Cooperative Oncology Group Study. J Clin Oncol 4 (1986) 702-709
14. Stanley K.E. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65 (1980) 25-32
15. Gridelli C., Aapro M., Ardizzoni A., Balducci L., De Marinis F., Kelly K., et al. Treatment of advanced non small cell lung cancer in the elderly: results of an International Expert Panel. J Clin Oncol 23 (2005) 3125-3137
16. Non Small Cell Lung Cancer Collaborative Group. Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311 (1995) 899-909
17. Frasci G. Chemotherapy of lung cancer in the elderly. Crit Rev Oncol Hematol 41 (2002) 349-361
18. Earle C.C., Tsai J.S., Gelber R.D., Weinstein M.C., Neumann P.J., and Weeks J.C. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 19 4 (2001) 1064-1070
19. Kosty M., Fleischman S.B., Herndon J.E., Coughlin K., Komblith A.B., Scalzo A., et al. Cisplatin, vinblastine, and hydrazine sulfate in advanced non-small celllung cancer: a randomized placebo-controlled double-blind phase III study of the Cancer and Leukemia Group B. J Clin Oncol 112 (1994) 1113-1120
20. Clamon G., Herndon J., Cooper R., Chang A.Y., Rosenman J., and Green M.R. Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: a phase III trial of the C ancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 4-11
21. Rocha Lima C.M.S., Herndon J.E., Kosty M., Clamon G., and Green M.R. Therapy choices among older patients with lung carcinoma. An evaluation of two trials of the Cancer and Leukemia Group B. Cancer 94 (2002) 181-187
22. Jatoi A., Hillman S., Stella P., Green E., Adjei A., Nair S., et al. Should elderly non-small cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 23 (2005) 9113-9119
23. Gridelli C. The elderly lung cancer, Vinorelbine Italian Study Group: effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 19 (1999) 66-72
24. Shepherd F.A., Abratt R.P., Anderson H., Gatzemeier U., Anglin G., and Iglesias J. Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer. Semin Oncol 24 Suppl. 7 (1997) 750-755
25. Frasci G., Lorusso V., Panza N., Comella P., Nicolella G., Bianco A., et al. Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small cell lung cancer. J Clin Oncol 18 (2000) 2529-2536
26. Gridelli C., Perrone F., Gallo C., Cigolari S., Rossi A., Piantedosi F., et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) pahse III randomized trial. J Natl Cancer Inst 95 5 (2003) 362-372
27. Sandler A.B., Nemunaitis J., Denham C., et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18 1 (2000) 122-130
28. Nguyen B., Sandler A., and Denham C. The safety and efficacy of gemcitabine plus cisplatin in the elderly chemo-naive NSCLC patients (age >70 years) as compared to those with age <70 years (abstract 1818). Proc Am Soc Clin Oncol 18 (1999) 471a
29. Langer C.J., Manola J., Bernardo P., et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 94 3 (2002) 173-181
30. Maestu I., Gomez-Aldaravi L., Torregrosa M.D., Camps C., Llorca C., Bosch C., et al. Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer. Lung Cancer 42 3 (2003) 345-354
31. Berardi R., Porfiri E., Scartozzi M., Lippe P., Silva R.R., Nacciarriti D., et al. Elderly patients with advanced non-small cell lung cancer. A phase II with weekly cisplatin and gemcitabine. Oncology 65 3 (2003) 198-203
32. LeCaer H., Delhoume J.Y., Thomas P.A., Berard H., Paillotin D., Barriere J.R., et al. Multicenter phase II trial of carboplatin/vinorelbine in elderly patients with advanced non small cell lung cancer efficacy and impact on quality of life: Groupe Français de Pneumo-Cancerologie Study 9902. Clin Lung Cancer 7 2 (2005) 114-120
33. Giorgio C.G., Pappalardo A., Russo A., Giuffrida D., Santini D., Petralia G., et al. A phase II study of carboplatin and paclitaxel as first line chemotherapy in elderly patients with advanced non small cell lung cancer (NSCLC). Lung Cancer 51 (2006) 357-362
34. Balducci L., and Corcoran M.B. Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin N Am 14 (2000) 193-212
35. Stuck A.E., Siu A.L., Wieland G.D., Adams J., and Rubenstein L.Z. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342 (1993) 1032-1036
36. Repetto L., Fratino L., Audisio R.A., Venturino A., Gianni W., Vercelli M., et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian group for geriatric oncology study. J Clin Oncol 20 (2002) 494-502
37. Charlson M., Szatrowski T.P., Peterson J., and Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 47 (1994) 1245-1251
38. Firat S., Byhardt R.W., and Gore E. Comorbidity and Karnofsky performance score are independent prognostic factors in stage III non small cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Int J Radiat Oncol Biol Phys 54 2 (2002) 357-364
39. Siu L.L., Shepherd F.A., Murray N., Feld R., Pater J., and Zee B. Influence of age on the treatment of limited-stage small cell lung cancer. J Clin Oncol 14 (1996) 821-828
40. Shepherd F.A., Amdemichael E., Ewans W.K., Chalvardjian P., Hogg-Johnson S., Coates R., et al. Treatment of small cell lung cancer in the elderly. J Am Geriatr Soc 42 (1994) 64-70
41. Weinmann M., Jeremic B., Bamberg M., and Bokemeyer C. Treatment of lung cancer in elderly part II: small cell lung cancer. Lung Cancer 40 1 (2003) 1-16